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Global public goods and health
Richard D. Smith1
Health improvement requires collective
as well as individual action, and the health
of poor populations in particular requires
collective action between countries as well
as within them. Initiatives such as the
Global Fund to Fight AIDS, Tuberculosis
and Malaria reflect a growing awareness
of this fact. However, initiating, organizing
and financing collective actions for health
at the global level presents a challenge
to existing international organizations (1).
The concept of ‘‘global public goods’’
(GPGs) suggests one possible framework
for considering these issues (2). In this
expression, ‘‘goods’’ encompass a range
of physical commodities (such as bread,
books and shoes) but includes services
(such as security, information and travel),
distinguishing between private and public
goods. Most goods are ‘‘private’’ in
the sense that their consumption can be
withheld until a payment is made in
exchange for them, and once consumed
they cannot be consumed again. In
contrast, once ‘‘public’’ goods are provided
no one can be excluded from consuming
them (they are non-excludable), and one
person’s consumption of them does not
prevent anyone else’s (they are non-rival
in consumption) (3). For example, no one
in a population can be excluded from
benefiting from a reduction in risk of
infectious disease when its incidence is
reduced, and one person benefiting from
this reduction in risk does not prevent
anyone else from benefiting from it as well.
Global public goods are goods of this
kind whose benefits cross borders and
are global in scope. For example, reduc-
tions in carbon dioxide emissions will slow
global warming. It will be impossible to
exclude any country from benefiting from
this, and each country will benefit without
preventing another from doing so. Simi-
larly, the eradication of infectious diseases
of global scope, such as smallpox or polio,
provides a benefit from which no country
is excluded, and from which all countries
will benefit without detriment to others.
However, these attributes of public
goods give rise to a paradox: although
there is significant benefit to be gained
from them by many people, there is no
commercial incentive for producing them,
since enjoyment cannot be made condi-
tional on payment. With national public
goods, the government therefore
intervenes either financially, through such
mechanisms as taxation or licensing, or
with direct provision. But for global public
goods this is harder to do, because no
global government exists to ensure that
they are produced and paid for. The central
issue for health-related GPGs is how
best to ensure that the collective action
necessary for health is taken at the
international level.
Globalization of travel, changes in
technology, and the liberalization of trade
all affect health. Communicable diseases
spread more rapidly, often in drug-resis-
tant form (4), environmental degradation
reduces access to clean air and water,
and knowledge of traditional and modern
health technologies is increasingly pa-
tented and thusmade artificially excludable
(5). However, discussion of GPGs to
date has typically been broad-based and
multisectoral (for instance on the envir-
onment, international security and trade
agreements), and most of the discussion
within the health sector has been focused
on medical technologies (3, 6, 7).
This has left many questions unan-
swered (8). For example, is health itself
a GPG? Towhat extent doesmy (national)
health depend on your (national) health?
How many of the actions necessary to
global health — communicable disease
control, generation and dissemination of
medical knowledge, public health
infrastructure — constitute GPGs? What
contribution can the GPG concept make
to fulfilling these needs? Is international
financing for these GPGs best coordi-
nated through voluntary contributions,
global taxation systems, or market-based
mechanisms? Does the concept of GPGs
undermine or support concepts of equity
and human rights?
The first large-scale study of the
application of the GPG concept to the
health sector examines questions such as
these, and has just been published (8). The
study finds that, while the concept has
important limitations, for some areas of
health work it can offer guidance in the
financing and provision of global health
programmes. In these areas it provides a
framework for collective action at the
global level, demonstrates the advantages
for the rich in helping the poor, and
provides a rationale for industrialized
countries to use national health budgets
to complement traditional aid (as seen
in the Polio Eradication Initiative (9)).
Overall, the GPG concept will be
increasingly important as a rationale and
a guide for public health work in an era
of globalization. n
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